Abetis 10mg Tablet is used for
🛒 How to order this item?
100% Genuine Products, Guaranteed
Safe & Secure Payments, Always
Fast, Secure & Efficient Delivery
Proper Packaging
Show More
Hypertension is a chronic condition characterized by persistently elevated blood pressure, exerting excessive force against the walls of blood vessels. This heightened pressure can lead to serious health issues such as angina (chest pain), heart attack (due to blocked blood supply to the heart), and damage to vital organs like the brain, kidneys, and eyes. Factors contributing to the risk of hypertension include obesity, smoking, diabetes, excessive alcohol consumption, lack of physical activity, stress, and kidney diseases.
Olmesartan Medoxomil is classified as an antihypertensive medication, specifically used to manage high blood pressure. If untreated, hypertension significantly raises the risk of heart-related conditions such as heart attack, heart failure, stroke, irregular heartbeat, and various other complications.
Alcohol should not be taken while using Olmesartan Medoxomil. It may worsen the health condition.
Abetis 10 is not recommended during early pregnancy and must not be used after the third month of pregnancy, as it can cause serious harm to the baby. Consult your doctor before taking this medication.
Abetis 10 is not recommended for breastfeeding women. Your doctor may choose an alternative treatment, especially if you are breastfeeding a newborn or a premature baby. Consult your doctor for advice before taking this medication.
Do not drive or operate machinery if you feel dizzy or sleepy after taking Abetis 10. Consult your doctor for guidance before using this medication.
Abetis 10 should be used with caution in patients with kidney problems. Consult your doctor before taking this medication.
Abetis 10 is not recommended for patients with jaundice. It should be used with caution in patients with liver disease. Consult your doctor before taking this medication.
Abetis 10mg Tablet relaxes the blood vessels by blocking the action of a chemical that usually makes blood vessels tighter. This lowers the blood pressure, allowing the blood to flow more smoothly to different organs and the heart to pump more efficiently.
Common side effects in adults include dizziness, headache, diplopia, ataxia, nausea, blurred vision, somnolence, pharyngitis, and rash. In children, side effects include vomiting, diarrhea, infection, fever, abdominal pain, and tremor. Clinical trials reported adverse reactions similar to placebo, with dizziness being the only reaction occurring in more than 1% of patients treated with Abetis compared to placebo.
Abetis is used to treat hypertension and can be administered alone or with other antihypertensive medications.
Olmesartan, the active ingredient in Abetis, inhibits the vasoconstrictor effects of angiotensin II by selectively blocking its binding to the AT1 receptor in vascular smooth muscle. This prevents vasoconstriction, aldosterone release, cardiac stimulation, and renal sodium reabsorption, leading to lowered blood pressure. Unlike ACE inhibitors, olmesartan does not affect the response to bradykinin.
The dosage should be individualized. The usual starting dose is 20 mg once daily, which can be increased to 40 mg after two weeks if needed. Doses above 40 mg do not show additional benefits. No dosage adjustments are needed for elderly patients, those with moderate to marked renal impairment, or those with hepatic dysfunction. For patients with possible intravascular volume depletion, a lower starting dose should be considered. Abetis can be taken with or without food. Safety and effectiveness in pediatric patients have not been established.
No significant drug interactions have been reported with digoxin or warfarin. The bioavailability of olmesartan is not significantly altered by antacids. Abetis is not metabolized by the cytochrome P450 system, so interactions with drugs affecting these enzymes are unlikely. However, NSAIDs, including COX-2 inhibitors, may reduce renal function and attenuate the antihypertensive effect of olmesartan. Regular monitoring of renal function is recommended for patients taking both Abetis and NSAIDs
Olmesartan is contraindicated in patients with hypersensitivity to any component of the product.
Abetis is classified as Pregnancy Category C. It should be discontinued as soon as pregnancy is detected due to the risk of injury or death to the fetus. It is not known if olmesartan is excreted in human milk, but it is present in low concentrations in rat milk. A decision should be made to discontinue either nursing or the drug, considering the drug's importance to the mother.
Renal function changes may occur in susceptible individuals, particularly those with severe congestive heart failure. Monitoring of renal function is advised, as treatment with olmesartan may be associated with oliguria, progressive azotemia, and rare cases of acute renal failure and death.
Abetis 10 should be stored at room temperature, away from heat and direct light. Keep it away from the reach of children.
Disclaimer:
ePharma sole intention is to ensure that its consumers get proper
information as musch as possible. Although we do not guarantee the
accuracy and the completeness of the information that provided and
here information is for informational purposes only.
The information contained herein should NOT be used as a substitute
for the advice of a qualified physician. This may not cover
everything about particular health conditions,
lab tests, medicines, all possible side effects, drug interactions,
warnings, alerts, etc. Please consult your healthcare professional
and discuss all your queries related to any disease or medicine. We
intend to support, not replace, the doctor-patient relationship.